International, Multicenter, Study of One-year, Open-label, Titrated Oral Tolvaptan Tablet Administration in Patients With Chronic Hyponatremia

PHASE3CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Hyponatremia
Interventions
DRUG

Tolvaptan

Once Daily

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT02449044 - International, Multicenter, Study of One-year, Open-label, Titrated Oral Tolvaptan Tablet Administration in Patients With Chronic Hyponatremia | Biotech Hunter | Biotech Hunter